# Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients

Study · id `cardio:ct-nct04932928` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04932928](<https://clinicaltrials.gov/study/NCT04932928>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04932928

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.

## Technical summary

Registry record NCT04932928. Randomized; no masking; primary purpose treatment. Start 2021-03-23 (actual); primary completion 2022-09-23 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 126 participants (planned count; ClinicalTrials.gov record NCT04932928, source copy `cardio:ctgov-nct04932928-2021-06-21`, retrieved 2026-10-26)
- Started: 2021-03-23 (actual) (ClinicalTrials.gov record NCT04932928, source copy `cardio:ctgov-nct04932928-2021-06-21`, retrieved 2026-10-26)
- Primary completion: 2022-09-23 (anticipated) (ClinicalTrials.gov record NCT04932928, source copy `cardio:ctgov-nct04932928-2021-06-21`, retrieved 2026-10-26)
- Completion: 2023-03-23 (anticipated) (ClinicalTrials.gov record NCT04932928, source copy `cardio:ctgov-nct04932928-2021-06-21`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04932928, source copy `cardio:ctgov-nct04932928-2021-06-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04932928-2021-06-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients
- Acronym: PDF
- Condition: Diabetes Mellitus, Type 2
- Condition: Lifestyle Risk Reduction
- Intervention (Device): FreeStyle Libre
- Intervention (Device): Blood glucose meter
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER
- Collaborator: Inje University
- Collaborator class: OTHER
- Collaborator: Kangbuk Samsung Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)
- Registry lists this organization as a collaborator: Inje University (`cardio:org-inje-university`)
- Registry lists this organization as a collaborator: Kangbuk Samsung Hospital (`cardio:org-kangbuk-samsung-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study (`cardio:pubmed-35984640`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 075573b6ebeca27e6383fc51feb14af9deefed52767038cd7a9146ab0d029509
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
